Susanne Lassieur Robertson, MD
Pediatrics · Cabot, ARNPI 1578520227
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $523, 2.9 times the $182 reported in 2019. Among pediatrics clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$358
- Abbott$282
- Novo Nordisk$216
- Amgen$148
- Lilly USA, LLC$145
- Ironshore Pharmaceuticals Inc.$132
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,617100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 24 | $358 |
| Abbott | 14 | $282 |
| Novo Nordisk | 15 | $216 |
| Amgen(2 entities) | 9 | $148 |
| Lilly USA, LLC | 9 | $145 |
| Ironshore Pharmaceuticals Inc. | 8 | $132 |
| Supernus Pharmaceuticals, Inc. | 3 | $119 |
| Corium, LLC | 6 | $113 |
| Merck | 7 | $112 |
| Pfizer | 6 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $74 |
| Eisai Inc. | 5 | $69 |
| Amarin Pharma, Inc. | 4 | $68 |
| Astellas Pharma US Inc | 3 | $50 |
| Sanofi Pasteur Inc. | 3 | $48 |
| Silk Road Medical, Inc. | 2 | $37 |
| Johnson & Johnson | 3 | $36 |
| Exact Sciences | 2 | $34 |
| AstraZeneca | 2 | $34 |
| Boston Scientific | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Bausch Health US, LLC | 2 | $28 |
| Dexcom, Inc. | 2 | $27 |
| Boehringer Ingelheim | 2 | $26 |
| AbbVie | 1 | $26 |
| Mylan Specialty L.p. | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 2 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $23 |
| Antares Pharma, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$2,617 in reported general payments places this provider in the 95th percentile of 464 pediatrics providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva RespimatTiotropium Bromide | 11 | $15,527 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $12,662 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 34 | $10,632 |
| OzempicSemaglutide | 11 | $9,970 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 41 | $9,027 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $4,814 |
| Levothyroxine Sodium | 141 | $1,516 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $1,514 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $1,142 |
| Adacel TdapDiph,pertuss(Acell),tet Vac/Pf | 16 | $1,116 |
| Atorvastatin Calcium | 106 | $938 |
| Gabapentin | 69 | $919 |
| Bupropion XlBupropion Hcl | 22 | $822 |
| Omeprazole | 70 | $784 |
| Potassium Chloride | 38 | $630 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Shingrix | $358 | $21,68953 claims |
| Boehringer IngelheimSpiriva Respimat | $26 | $15,52711 claims |
| PfizerAbrysvo | $111 | $10,63234 claims |
| Novo NordiskOzempic | $216 | $9,97011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 464 pediatrics providers in Arkansas.
Other pediatrics in Cabot
- Howard OrsburnRussellville$71K
- David GoodmanWest Memphis$61K
- Robert PesekLittle Rock$20K
- Peyton MillsLittle Rock$7K
- Rachel WhiteJacksonville$5K
- Eduardo OchoaLittle Rock$4K
- Laura MarrattLittle Rock$4K
- Jane MiersSherwood$4K
- Jennifer JohnsonFort Smith$4K
- Ashley DavisSherwood$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.